Nature of Inhibition of Mitochondrial Respiratory Complex I by 6-Hydroxydopamine |
| |
Authors: | Y. Glinka K. F. Tipton M. B. H. Youdim |
| |
Affiliation: | Technion, Department of Pharmacology, Faculty of Medicine, Rappoport Family Research Institute, Haifa, Israel;and; Department of Biochemistry, Trinity College Dublin, Dublin, Ireland |
| |
Abstract: | Abstract: The catecholaminergic neurotoxin 6-hydroxydopamine causes parkinsonian symptoms in animals and it has been proposed that reactive oxygen species and oxidative stress, enhanced by iron, may play a key role in its toxicity. The present results demonstrate that 6-hydroxydopamine reversibly inhibits complex I (NADH dehydrogenase) of brain mitochondrial respiratory chain in isolated mitochondria. 6-Hydroxydopamine itself, rather than its oxidative products, was responsible for the inhibition. Iron(III) did not enhance inhibition but decreased it by stimulating the nonenzyme oxidation of 6-hydroxydopamine. Inhibition was potentiated to some extent by calcium ion. Desferrioxamine protected complex I activity against the inhibition, but it was not due to its chelator or antioxidative properties. Desferrioxamine was also shown to activate NADH dehydrogenase in the absence of 6-hydroxydopamine. Activation of mitochondrial respiration by desferrioxamine may contribute to the enhanced neuron survival in the presence of desferrioxamine in some neurodegenerative conditions. |
| |
Keywords: | Mitochondrial complex I 6-Hydroxydopamine Mechanism of inhibition Iron Calcium Desferrioxamine Protection Oxidative stress |
|
|